- Raytheon Technologies Corporation (NYSE:RTX) has secured a $237 million U.S. Army contract for Ku-band Radio Frequency Sensors (KuRFS) and Coyote effectors to detect and defeat unmanned aircraft.
- The contract includes a combination of fixed-site and mobile systems and a quantity of effectors, designated to support the Army’s U.S Central Command operations.
- “The KuRFS radar and Coyote effectors effectively detect and defeat unmanned aircraft systems, an increasingly evident and global threat. LIDS is operationally deployed, providing a proven, reliable, and essential layer of defense against enemy drones,” said Tom Laliberty, president of Land Warfare & Air Defense at Raytheon Missiles & Defense.
- The U.S. Army’s LIDS integrates KuRFS and the Coyote family of effectors with Northrop Grumman Corporation’s (NYSE:NOC) Forward Area Air Defense Command and Control system, and Syracuse Research Corporation’s electronic warfare system.
- Price Action: RTX shares are trading lower by 0.18% at $104.47 on the last check Wednesday.
- Photo Via Company
AstraZeneca Announced Enhertu Approved in the EU for Patients With HER2-Positive Metastatic Breast Cancer Treated With One or More Prior Anti-HER2-based Regimens
Approval broadens indication for AstraZeneca and Daiichi Sankyo's Enhertu across Europe to earlier use in HER2-positive metastatic breast cancer. Based on ground-breaking DESTINY-Breast03 results in which Enhertu demonstrated a 72% reduction in the risk of disease progression or death vs. trastuzumab emtansine (T-DM1).
